(RTTNews) - Esperion Therapeutics, Inc. (ESPR) Monday announced that it has entered into a settlement agreement with Micro Labs USA, Inc. and its affiliate Micro Labs Ltd. to resolve a patent ...

Esperion settles patent litigation with Micro Labs, extending protection for NEXLETOL until April 2040, with ongoing litigation against other defendants. Esperion has reached a settlement with ...